Show simple item record

dc.contributor.authorWu, Yangfeng
dc.contributor.authorLi, Shenshen
dc.contributor.authorPatel, Anushka
dc.contributor.authorLi, Xian
dc.contributor.authorDu, Xin
dc.contributor.authorWu, Tao
dc.contributor.authorZhao, Yifei
dc.contributor.authorFeng, Lin
dc.contributor.authorBillot, Laurent
dc.contributor.authorPeterson, Eric D
dc.contributor.authorWoodward, Mark
dc.contributor.authorKong, Lingzhi
dc.contributor.authorHuo, Yong
dc.contributor.authorHu, Dayi
dc.contributor.authorChalkidou, Kalipso
dc.contributor.authorGao, Runlin
dc.contributor.authorfor the CPACS-3 Investigators
dc.date.accessioned2019-12-20T04:46:22Z
dc.date.available2019-12-20T04:46:22Z
dc.date.issued2019
dc.identifier.issn2380-6583
dc.identifier.doi10.1001/jamacardio.2019.0897
dc.identifier.urihttp://hdl.handle.net/10072/389914
dc.description.abstractImportance: Prior observational studies suggest that quality of care improvement (QCI) initiatives can improve the clinical outcomes of acute coronary syndrome (ACS). To our knowledge, this has never been demonstrated in a well-powered randomized clinical trial. Objective: To determine whether a clinical pathway-based, multifaceted QCI intervention could improve clinical outcomes among patients with ACS in resource-constrained hospitals in China. Design, Setting, Participants: This large, stepped-wedge cluster randomized clinical trial was conducted in nonpercutaneous coronary intervention hospitals across China and included all patients older than 18 years and with a final diagnosis of ACS who were recruited consecutively between October 2011 and December 2014. We excluded patients who died before or within 10 minutes of hospital arrival. We recruited 5768 and 0 eligible patients for the control and intervention groups, respectively, in step 1, 4326 and 1365 in step 2, 3278 and 3059 in step 3, 1419 and 4468 in step 4, and 0 and 5645 in step 5. Interventions: The intervention included establishing a QCI team, training clinical staff, implementing ACS clinical pathways, sequential site performance assessment and feedback, online technical support, and patient education. The usual care was the control that was compared. Main Outcomes and Measures: The primary outcome was the incidence of in-hospital major adverse cardiovascular events (MACE), comprising all-cause mortality, reinfarction/myocardial infarction, and nonfatal stroke. Secondary outcomes included 16 key performance indicators (KPIs) and the composite score developed from these KPIs. Results: Of 29 346 patients (17 639 men [61%]; mean [SD] age for control, 64.1 [11.6] years; mean [SD] age for intervention, 63.9 [11.7] years) who were recruited from 101 hospitals, 14 809 (50.5%) were in the control period and 14 537 (49.5%) were in the intervention period. There was no significant difference in the incidence of in-hospital MACE between the intervention and control periods after adjusting for cluster and time effects (3.9% vs 4.4%; odds ratio, 0.93; 95% CI, 0.75-1.15; P = .52). The intervention showed a significant improvement in the composite KPI score (mean [SD], 0.69 [0.22] vs 0.61 [0.23]; P < .01) and in 7 individual KPIs, including the early use of antiplatelet therapy and the use of appropriate secondary prevention medicines at discharge. No unexpected adverse events were reported. Conclusions and Relevance: Among resource-constrained Chinese hospitals, introducing a multifaceted QCI intervention had no significant effect on in-hospital MACE, although it improved a few of the care process indicators of evidence-based ACS management. Trial Registration: ClinicalTrials.gov identifier: NCT01398228.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherAmerican Medical Association
dc.publisher.placeUnited States
dc.relation.ispartofpagefrom418
dc.relation.ispartofpageto427
dc.relation.ispartofissue5
dc.relation.ispartofjournalJAMA Cardiology
dc.relation.ispartofvolume4
dc.subject.fieldofresearchPublic Health and Health Services
dc.subject.fieldofresearchcode1117
dc.subject.keywordsASSOCIATION TASK-FORCE
dc.subject.keywordsGLOBAL BURDEN
dc.subject.keywordsSYSTEMATIC ANALYSIS
dc.subject.keywordsIMPROVING QUALITY
dc.subject.keywordsHEALTH-CARE
dc.titleEffect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in China A Randomized Clinical Trial
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationWu, Y; Li, S; Patel, A; Li, X; Du, X; Wu, T; Zhao, Y; Feng, L; Billot, L; Peterson, ED; Woodward, M; Kong, L; Huo, Y; Hu, D; Chalkidou, K; Gao, R; ; for the CPACS-3 Investigators, Effect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in China A Randomized Clinical Trial, JAMA Cardiology, 2019, 4 (5), pp. 418-427
dc.date.updated2019-12-19T03:52:35Z
gro.hasfulltextNo Full Text
gro.griffith.authorChalkidou, Kalipso


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record